{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,12]],"date-time":"2026-06-12T20:57:30Z","timestamp":1781297850492,"version":"3.54.1"},"reference-count":23,"publisher":"The Journal of Rheumatology","issue":"6","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J Rheumatol"],"accepted":{"date-parts":[[2026,1,12]]},"published-print":{"date-parts":[[2026,6]]},"abstract":"<jats:sec>\n                    <jats:title>Objective<\/jats:title>\n                    <jats:p>Systemic sclerosis (SSc) gastrointestinal (GI) disease is heterogeneous in presentation, with individual symptoms lacking specificity for specific anatomical and functional abnormalities. We used factor analysis to investigate whether latent subgroups of SSc-GI symptoms can be detected.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>Using the University of California, Los Angeles Scleroderma Clinical Trials Consortium Gastrointestinal 2.0 (GIT 2.0) questionnaire data from 773 Australian Scleroderma Cohort Study participants, we performed a factor analysis of, firstly, GIT 2.0 domains scores, and then individual GIT 2.0 question responses to identify latent factors. A subsequent cluster analysis was performed to explore whether clinically definable SSc phenotypes were associated with specific GI symptoms.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>SSc-GI symptoms were highly correlated. Factor analysis of individual GIT 2.0 question responses revealed 4 latent factors within the dataset that could be clinically described as upper GI tract symptoms, bloating, diarrhea and incontinence, and constipation. Cluster analysis revealed 2 patient clusters, distinguished by disease duration and severity of GI manifestations. Anticentromere antibodies and pulmonary arterial hypertension were more common in participants with severe GI disease.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>Despite the high correlation between GI manifestations, it is possible to detect subgroups of SSc-GI symptoms. Improved understanding of these subgroups of SSc-GI disease may advance the discovery of targeted interventions to improve the daily function and quality of life of those living with SSc.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.3899\/jrheum.2025-0982","type":"journal-article","created":{"date-parts":[[2026,2,2]],"date-time":"2026-02-02T12:05:19Z","timestamp":1770033919000},"page":"652-658","source":"Crossref","is-referenced-by-count":1,"title":["Factor Analysis to Determine Subgroups of Gastrointestinal Symptoms in Systemic Sclerosis"],"prefix":"10.3899","volume":"53","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-4636-729X","authenticated-orcid":false,"given":"Laura","family":"Ross","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dylan","family":"Hansen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Susanna","family":"Proudman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jennifer","family":"Walker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wendy","family":"Stevens","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nava","family":"Ferdowsi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joanne","family":"Sahhar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gene-Siew","family":"Ngian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1078-6732","authenticated-orcid":false,"given":"Diane","family":"Apostolopoulos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3480-7251","authenticated-orcid":false,"given":"Lauren V.","family":"Host","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mandana","family":"Nikpour","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chamara","family":"Basnayake","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3750-6569","authenticated-orcid":false,"given":"Elizabeth R.","family":"Volkmann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"2262","published-online":{"date-parts":[[2026,2,1]]},"reference":[{"key":"2026061213100661000_53.6.652.1","doi-asserted-by":"crossref","first-page":"1686","DOI":"10.1002\/acr.25426","article-title":"Prevalence and outcomes of gastrointestinal manifestations in an Australian scleroderma cohort","volume":"76","author":"Quinlivan","year":"2024","journal-title":"Arthritis Care Res"},{"key":"2026061213100661000_53.6.652.2","doi-asserted-by":"publisher","DOI":"10.1038\/s41584-022-00900-6"},{"key":"2026061213100661000_53.6.652.3","doi-asserted-by":"publisher","DOI":"10.1002\/art.24730"},{"key":"2026061213100661000_53.6.652.4","first-page":"57","article-title":"Associations between a scleroderma-specific gastrointestinal instrument and objective tests of upper gastrointestinal involvements in systemic sclerosis","volume":"31","author":"Bae","year":"2013","journal-title":"Clin Exp Rheumatol"},{"key":"2026061213100661000_53.6.652.5","doi-asserted-by":"crossref","first-page":"741","DOI":"10.1111\/1346-8138.17202","article-title":"Reliability, validity, and sensitivity of the Japanese version of the University of California, Los Angeles scleroderma clinical trial consortium gastrointestinal tract instrument: application to efficacy assessment of intravenous immunoglobulin administration","volume":"51","author":"Matsuda","year":"2024","journal-title":"J Dermatol"},{"key":"2026061213100661000_53.6.652.6","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1177\/2397198321992197","article-title":"Responsiveness of the University of California, Los Angeles Scleroderma Clinical Trial Consortium gastrointestinal tract 2.0 (UCLA-SCTC-GIT 2.0)to change in scleroderma patients","volume":"6","author":"Suliman","year":"2021","journal-title":"J Scleroderma Relat Disord"},{"key":"2026061213100661000_53.6.652.7","doi-asserted-by":"publisher","DOI":"10.3899\/jrheum.180004"},{"key":"2026061213100661000_53.6.652.8","doi-asserted-by":"crossref","first-page":"442","DOI":"10.1002\/acr.24488","article-title":"Relationship between gastrointestinal transit, Medsger gastrointestinal severity, and University of California, Los Angeles Scleroderma Clinical Trial Consortium gastrointestinal Tract 2.0 symptoms in patients with systemic sclerosis","volume":"74","author":"McMahan","year":"2022","journal-title":"Arthritis Care Res"},{"key":"2026061213100661000_53.6.652.9","doi-asserted-by":"publisher","DOI":"10.1186\/s13075-021-02506-x"},{"key":"2026061213100661000_53.6.652.10","doi-asserted-by":"publisher","DOI":"10.1136\/annrheumdis-2013-204424"},{"key":"2026061213100661000_53.6.652.11","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2036.2003.01805.x"},{"key":"2026061213100661000_53.6.652.12","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1097\/MCG.0b013e3181f423ea","article-title":"Factor analysis demonstrates a symptom cluster related to methane and non-methane production in irritable bowel syndrome","volume":"45","author":"Makhani","year":"2011","journal-title":"J Clin Gastroenterol"},{"key":"2026061213100661000_53.6.652.13","doi-asserted-by":"crossref","first-page":"e14268","DOI":"10.1111\/nmo.14268","article-title":"Characteristics of, and natural history among, individuals with Rome IV functional bowel disorders","volume":"34","author":"Goodoory","year":"2022","journal-title":"Neurogastroenterol Motil"},{"key":"2026061213100661000_53.6.652.14","doi-asserted-by":"publisher","DOI":"10.3748\/wjg.v17.i11.1468"},{"key":"2026061213100661000_53.6.652.15","doi-asserted-by":"publisher","DOI":"10.1053\/j.gastro.2016.03.035"},{"key":"2026061213100661000_53.6.652.16","doi-asserted-by":"crossref","first-page":"SI64","DOI":"10.1093\/rheumatology\/keac444","article-title":"Differences in symptom experience among patients with systemic sclerosis: a cluster analytic approach to identifying subgroups","volume":"62","author":"Murphy","year":"2023","journal-title":"Rheumatology"},{"key":"2026061213100661000_53.6.652.17","doi-asserted-by":"crossref","first-page":"1553","DOI":"10.1002\/art.40906","article-title":"Phenotypes determined by cluster analysis and their survival in the prospective European Scleroderma Trials and Research cohort of patients with systemic sclerosis","volume":"71","author":"Sobanski","year":"2019","journal-title":"Arthritis Rheumatol"},{"key":"2026061213100661000_53.6.652.18","first-page":"1656","article-title":"Gastrointestinal disorders in systemic sclerosis: cluster analysis and prognosis from a French prospective cohort","volume":"42","author":"Molli\u00e8re","year":"2024","journal-title":"Clin Exp Rheumatol"},{"key":"2026061213100661000_53.6.652.19","doi-asserted-by":"publisher","DOI":"10.1093\/rheumatology\/keaf433"},{"key":"2026061213100661000_53.6.652.20","doi-asserted-by":"publisher","DOI":"10.1002\/acr.25080"},{"key":"2026061213100661000_53.6.652.21","doi-asserted-by":"publisher","DOI":"10.1186\/s13075-017-1250-z"},{"key":"2026061213100661000_53.6.652.22","doi-asserted-by":"publisher","DOI":"10.1093\/rheumatology\/keae469"},{"key":"2026061213100661000_53.6.652.23","doi-asserted-by":"crossref","first-page":"2252","DOI":"10.1002\/art.1780401222","article-title":"Esophageal dysfunction in scleroderma: relationship with disease subsets","volume":"40","author":"Bassotti","year":"1997","journal-title":"Arthritis Rheum"}],"container-title":["The Journal of Rheumatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.3899\/jrheum.2025-0982","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,12]],"date-time":"2026-06-12T20:10:21Z","timestamp":1781295021000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.jrheum.org\/lookup\/doi\/10.3899\/jrheum.2025-0982"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2,1]]},"references-count":23,"journal-issue":{"issue":"6","published-online":{"date-parts":[[2026,6,1]]},"published-print":{"date-parts":[[2026,6]]}},"alternative-id":["10.3899\/jrheum.2025-0982"],"URL":"https:\/\/doi.org\/10.3899\/jrheum.2025-0982","relation":{},"ISSN":["0315-162X","1499-2752"],"issn-type":[{"value":"0315-162X","type":"print"},{"value":"1499-2752","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,2,1]]}}}